MYCN and neuroblastoma: We have found that AhR transcriptional activity correlates with poor patient prognosis, positively regulates MycN, and represses differentiation of MYCN-amplified neuroblastoma cells by altering chromatin accessibility and modulating the retinoic acid receptor pathway (70).